Thymus removal and immunity in infant heart surgery
Part of Genetic & congenital, Heart & circulation, Immune system & allergy, Infections clinical trials.
This study looks at how removing the thymus gland during infant heart surgery affects the immune system. It compares babies who have their thymus removed with those who have heart surgery without removing it, and with babies having other types of surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between newborn and 6 months old.
- Your child must have been born full-term (at least 37 weeks of pregnancy).
- Your child needs heart surgery at Nantes University Hospital.
- All follow-up care after surgery will be at Nantes University Hospital.
- You (the parent or guardian) must sign a consent form to allow your child to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of surgically removing the thymus: a camera-assisted approach through the chest versus an approach through an opening under the breastbone. It may help people with thymus tumors or certain types of myasthenia gravis when medicines alone have not worked well.
This study looks at how a serious heart condition before birth may affect a baby's brain development. It follows babies and their parents to better understand and support these children as they grow.
This study looks at how the heart makes new muscle cells in babies under 1 year old who need heart surgery. Tissue that is normally removed during surgery will be studied to learn more about heart repair.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
This early-phase study tests a cell treatment (Treg cells made from a child’s thymus tissue) to help prevent the body from rejecting a new heart. It may help reduce rejection risk, but it is experimental and involves added risks and follow-up.
This trial tests new surgical strategies for newborns with certain complex heart conditions. It aims to see which techniques lead to better recovery and quality of life in the first year after surgery.
Hear when a new Thymectomy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.